Carbon Monoxide-induced Coma: Prognostic Factors
Coma-CO
Prognostic Factors of Carbon Monoxide-induced Coma Treated by Hyperbaric Oxygen: a Retrospective Study
1 other identifier
observational
212
1 country
1
Brief Summary
The primary objective of the study is to determine prognostic factors for hospital-mortality following carbon monoxide (CO)-induced coma. The secondary objective is to determine prognostic factors of CO related cognitive sequelae, at the time of hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2019
CompletedFirst Posted
Study publicly available on registry
April 24, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedJuly 7, 2020
November 1, 2019
2 months
April 15, 2019
July 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality rate
Mortality rate during the stay in hospital: patient alive or not at discharge or death
28-day
Secondary Outcomes (4)
Cognitive sequelae at hospital discharge
28-day
Cognitive sequelae at hospital discharge
28-day
Cognitive sequelae at hospital discharge
28-day
Cognitive sequelae at hospital discharge
28-day
Eligibility Criteria
All comatose patients (Glasgow coma score \<8) due to carbon monoxide poisoning, treated by hyperbaric oxygen therapy in a tertiary hospital in the greater Paris area were included in the current study
You may qualify if:
- All comatose patients (Glasgow coma score \<8) due to carbon monoxide poisoning, treated by hyperbaric oxygen therapy in a tertiary hospital in Île de France area;
- Aged ≥ 18 years;
- Hospitalized in hyperbaric medicine unity of Raymond Poincaré hospital in Garches.
You may not qualify if:
- Pregnant woman;
- Patient present clinical signes of stroke and without CO detection.
- In case of unusable data, patient will be excluded from study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Intensive Care Unit, Raymond Poincaré hospital
Garches, 92380, France
Related Publications (1)
Resche-Rigon M, White IR. Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat Methods Med Res. 2018 Jun;27(6):1634-1649. doi: 10.1177/0962280216666564. Epub 2016 Sep 19.
PMID: 27647809BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paris Meng, MD
Intensive Care Unit, Raymond Poincaré hospital
- STUDY DIRECTOR
Djillali ANNANE, MD, PhD
Intensive Care Unit, Raymond Poincaré hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2019
First Posted
April 24, 2019
Study Start
May 1, 2019
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
July 7, 2020
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share